Cargando…
Effect of azithromycin on incidence of acute respiratory exacerbations in children with HIV taking antiretroviral therapy and co-morbid chronic lung disease: a secondary analysis of the BREATHE trial
BACKGROUND: In the BREATHE trial weekly azithromycin decreased the rate of acute respiratory exacerbations (AREs) compared to placebo among children and adolescents with HIV-associated chronic lung disease (CLD) taking antiretroviral therapy (ART). The aim of this analysis was to identify risk facto...
Autores principales: | Price, Amy, McHugh, Grace, Simms, Victoria, Semphere, Robina, Ngwira, Lucky G, Bandason, Tsitsi, Mujuru, Hilda, Odland, Jon O, Ferrand, Rashida A, Rehman, Andrea M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599092/ https://www.ncbi.nlm.nih.gov/pubmed/34820609 http://dx.doi.org/10.1016/j.eclinm.2021.101195 |
Ejemplares similares
-
Adherence to additional medication for management of HIV-associated comorbidities among older children and adolescents taking antiretroviral therapy
por: Rehman, Andrea M., et al.
Publicado: (2022) -
The effect of azithromycin for management of HIV-associated chronic lung disease on right heart function: Results from the BREATHE trial
por: Majonga, Edith D., et al.
Publicado: (2021) -
Risk factors for sustained virological non-suppression among children and adolescents living with HIV in Zimbabwe and Malawi: a secondary data analysis
por: Jackson, Christi, et al.
Publicado: (2022) -
False-negative HIV tests using oral fluid tests in children taking antiretroviral therapy from Harare, Zimbabwe
por: Olaru, Ioana D., et al.
Publicado: (2017) -
High prevalence of echocardiographic abnormalities in older HIV-infected children taking antiretroviral therapy
por: Majonga, Edith D., et al.
Publicado: (2018)